a 215 oxycodone 30 mg actavis canada

a 215 oxycodone 30 mg actavis canada is a semisynthetic opioid analgesic derived from the baine in Germany in 1917.3 It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period. Label The first oxycodone containing product, Percodan, was approved by the FDA on April 12, 1950.

What is oxycodone?

a 215 oxycodone 30 mg actavis canada is an opioid pain medicine sometimes called a narcotic.

Oxycodone is used to treat moderate to severe pain.

The extended-release form of oxycodone is for around-the-clock treatment of pain and should not be used on an as-needed basis for pain.

Oxycodone

Generic Name: oxycodone (ox i KOE done)
Brand Names: Oxaydo, OxyContin, Oxyfast, Roxicodone, RoxyBond, Xtampza ER; oxycodone is also present in the following combination drugs: Combunox, Endocet, Endodan, Moxduo, Oxycodan, Percocet, Percodan, Primlev, Roxicet, Xartemis XR, and others

A 215 (Oxycodone Hydrochloride 30 mg)

Pill with imprint A 215 is Blue, Round and has been identified as Oxycodone Hydrochloride 30 mg. It is supplied by Actavis.

Oxycodone is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. FDA has not classified the drug for risk during pregnancy. Oxycodone 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Indication

Actavis oxycodone 30mg is indicated for the treatment of moderate to severe pain. There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.

Half life

The apparent elimination half life of oxycodone is 3.2 hours for immediate release formulations and 4.5 hours for extended release formulations. Noroxycodone has a half life of 5.8 hours, oxymorphone has a half life of 8.8 hours, noroxymorphone has a half life of 9 hours.

Route of elimination

a 215 oxycodone 30 mg actavis canada is mainly eliminated in the urine. Label Unbound noroxycodone makes up 23% of the dose recovered in urine and oxymorphone makes up <1%. conjugated oxymorphone makes up 10% of the recovered dose. Free and conjugated oxycodone makes up 8.9% of the recovered dose, noroxymorphone makes up 14%, and reduced metabolites make up 18%.

How should I use oxycodone?

Take Actavis oxycodone 30mg exactly as prescribed. Follow the directions on your prescription label and read all medication guides. Never use this medicine in larger amounts, or for longer than prescribed. Tell your doctor if you feel an increased urge to take more of oxycodone.

Before taking this medicine

You should not use Actavis oxycodone 30mg A215 if you are allergic to it, or if you have: severe asthma or breathing problems; or

a blockage in your stomach or intestines.

You should not use this medicine if you are already using a similar opioid medicine and are tolerant to it. Do not use this medicine if you have used a MAO inhibitor in the past 14 days, such as isocarboxazid, linezolid, phenelzine, rasagiline, selegiline, or tranylcypromine or have received a methylene blue injection.

What happens if I miss a dose?

Since Actavis oxycodone 30mg is used for pain, you are not likely to miss a dose. Skip any missed dose if it is almost time for your next dose. Do not use two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An oxycodone overdose can be fatal, especially in a child or other person using the medicine without a prescription.

Overdose can cause severe muscle weakness, pinpoint pupils, very slow breathing, extreme drowsiness, coma, and/or death.

What should I avoid while using oxycodone?

Do not drink alcohol. Dangerous side effects or death could occur.

Avoid driving or operating machinery until you know how this medicine will affect you. Dizziness or severe drowsiness can cause falls or other accidents.